- Home
- ARBK vs MRKR Comparison
ARBK vs MRKR Comparison
Compare ARBK & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBK
- MRKR
- Stock Information
- Founded
- ARBK 2017
- MRKR N/A
- Country
- ARBK United Kingdom
- MRKR United States
- Employees
- ARBK N/A
- MRKR N/A
- Industry
- ARBK Finance: Consumer Services
- MRKR Biotechnology: Pharmaceutical Preparations
- Sector
- ARBK Finance
- MRKR Health Care
- Exchange
- ARBK Nasdaq
- MRKR Nasdaq
- Market Cap
- ARBK 21.6M
- MRKR 17.7M
- IPO Year
- ARBK 2021
- MRKR N/A
- Fundamental
- Price
- ARBK $0.30
- MRKR $1.19
- Analyst Decision
- ARBK Hold
- MRKR Strong Buy
- Analyst Count
- ARBK 1
- MRKR 3
- Target Price
- ARBK N/A
- MRKR $13.17
- AVG Volume (30 Days)
- ARBK 6.2M
- MRKR 3.5M
- Earning Date
- ARBK 08-27-2025
- MRKR 08-18-2025
- Dividend Yield
- ARBK N/A
- MRKR N/A
- EPS Growth
- ARBK N/A
- MRKR N/A
- EPS
- ARBK N/A
- MRKR N/A
- Revenue
- ARBK $47,017,000.00
- MRKR $5,696,123.00
- Revenue This Year
- ARBK $183.90
- MRKR N/A
- Revenue Next Year
- ARBK $26.78
- MRKR $7.16
- P/E Ratio
- ARBK N/A
- MRKR N/A
- Revenue Growth
- ARBK N/A
- MRKR 71.53
- 52 Week Low
- ARBK $0.15
- MRKR $0.95
- 52 Week High
- ARBK $1.55
- MRKR $5.95
- Technical
- Relative Strength Index (RSI)
- ARBK 45.68
- MRKR 35.51
- Support Level
- ARBK $0.28
- MRKR $1.15
- Resistance Level
- ARBK $0.34
- MRKR $1.61
- Average True Range (ATR)
- ARBK 0.04
- MRKR 0.12
- MACD
- ARBK -0.00
- MRKR -0.04
- Stochastic Oscillator
- ARBK 14.93
- MRKR 16.36
About ARBK Argo Blockchain plc
Argo Blockchain PLC is a blockchain technology company focused on the large-scale mining of Bitcoin. It mines bitcoin using purpose-built computers (or mining machines) to solve complex cryptographic algorithms on the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company acquires and deploys mining technology solutions in North American facilities that utilize predominantly renewable and inexpensive electricity.
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.